Shenglin Ma

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text

Medicine, Oncology, Pharmacology +14

Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study

Jun Peng, Shenglin Ma, J. Liu et al. · Journal of Thrombosis and Haemostasis · 2014 · 125 citations · Full text

Life Sciences, Hematology, Immunology +17

S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1

Yasi Xu, Dan Su, Lucheng Zhu et al. · Journal of Ovarian Research · 2018 · 67 citations · Full text

Medicine, Molecular Biology, Oncology +14

Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals

Gang Deng, Ronghao Wang, Yin Sun et al. · Cell Death and Differentiation · 2021 · 60 citations · Full text

Medicine, Oncology, Urology +17

s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamide

Peihua Luo, Hao Yan, Xueqin Chen et al. · Cell Research · 2020 · 44 citations · Full text

Medicine, Oncology, Pharmacology +16